A Montana woman pleaded guilty on December 16, 2025, to one count of tampering with consumer products at a healthcare center in Jordan, Montana, US Attorney Kurt Alme announced. The 35-year-old defendant faces up to 10 years in prison, a $250,000 fine, and at least three years of supervised release.
According to court documents, the defendant was discovered on January 19, 2023, tampering with controlled substances at the healthcare center, where she worked as the director of nursing. Facility staff entered her locked office to retrieve a narcotics log and observed several suspicious items, including hospital stock narcotics, an IV pole, tourniquets, needles, IV equipment, replacement vial caps, replacement medication labels, and what appeared to be blood on multiple surfaces.
During a subsequent search of the office, staff and law enforcement located numerous vials of fentanyl that appeared to have been tampered with, including vials with caps removed and replaced or that had been emptied. Investigators also found other controlled substances that had allegedly been replaced.
Facility staff reported concerns that patients may have received saline solution instead of prescribed pain medication in the months leading up to the incident. A forensic chemist with the Food and Drug Administration (FDA) later analyzed the seized containers and concluded the controlled substances had been tampered with and adulterated.
The US Attorney’s Office is prosecuting the case. The Drug Enforcement Administration, the FDA, and the Garfield County Sheriff’s Office conducted the investigation.
Compliance Perspective
Issue
Drug diversion or tampering by healthcare staff poses serious risks to patient safety and can constitute abuse, neglect, misappropriation, and criminal conduct. Nurses and other staff with access to controlled substances may be able to divert or tamper with medications, making proactive prevention, detection, and response programs critical for every facility. Failure to implement such programs can result in serious harm to patients, legal and regulatory consequences, and potential criminal liability for staff. Facilities should be aware of the signs of diversion or tampering, including missing medications, altered or empty vials, unusual behaviors, and improper documentation.
Discussion Points
- Review your policies and procedures on preventing, identifying, and responding to drug diversion or tampering. Ensure procedures clearly outline steps for staff to follow when they suspect or identify tampering. Periodic policy reviews conducted with a compliance or regulatory consultant can help identify gaps and align policies with current best practices.
- Train appropriate staff on preventing, identifying, and responding to any suspicion of drug diversion or tampering. Emphasize the impact on patient safety, staff responsibility to report concerns immediately, and potential legal and regulatory consequences. Med-Net Academy offers the course Drug Diversion: What Every Nursing Facility Needs to Know, which covers commonly abused prescription medications, warning signs of staff substance use disorders, indicators of possible drug diversion, and steps staff can take to prevent and respond to diversion incidents.
- Conduct regular audits of controlled substances to ensure proper documentation and accountability. This should include reconciliation of narcotics logs, verification of medication storage, and monitoring for unusual patterns or discrepancies. Targeted audits, including those performed in coordination with a consultant pharmacist or compliance specialist, can help detect potential diversion or tampering early and reinforce a safe and compliant environment.
*This news alert has been prepared by Med-Net Concepts, Inc. for informational purposes only and is not intended to provide legal advice.*